CAVIN1
Basic information
Region (hg38): 17:42402449-42423256
Previous symbols: [ "PTRF" ]
Links
Phenotypes
GenCC
Source:
- Berardinelli-Seip congenital lipodystrophy (Supportive), mode of inheritance: AR
- congenital generalized lipodystrophy type 4 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Lipodystrophy, congenital generalized, type 4 | AR | Cardiovascular | Among other manifestations, individuals may demonstrate cardiac arrhythmias, and appropriate surveillance and management may be beneficial | Cardiovascular; Endocrine; Gastrointestinal; Musculoskeletal | 12116229; 18698612; 19726876; 20300641; 20684003 |
ClinVar
This is a list of variants' phenotypes submitted to
- Congenital generalized lipodystrophy type 4 (1 variants)
- Congenital generalized lipodystrophy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAVIN1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 15 | |||||
missense | 38 | 39 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 22 | 17 | 19 | 58 | ||
Total | 2 | 4 | 66 | 27 | 20 |
Variants in CAVIN1
This is a list of pathogenic ClinVar variants found in the CAVIN1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-42402476-C-T | Congenital generalized lipodystrophy type 4 | Likely benign (Jan 13, 2018) | ||
17-42402572-C-A | Congenital generalized lipodystrophy type 4 | Uncertain significance (Jan 12, 2018) | ||
17-42402639-A-G | Congenital generalized lipodystrophy type 4 | Likely benign (Jan 13, 2018) | ||
17-42402697-T-G | Congenital generalized lipodystrophy type 4 | Uncertain significance (Jan 13, 2018) | ||
17-42402732-A-G | Congenital generalized lipodystrophy type 4 | Uncertain significance (Jan 12, 2018) | ||
17-42402775-G-A | Congenital generalized lipodystrophy type 4 | Likely benign (Jan 13, 2018) | ||
17-42402792-G-C | Congenital generalized lipodystrophy type 4 | Uncertain significance (Jan 13, 2018) | ||
17-42402831-G-A | Congenital generalized lipodystrophy type 4 | Likely benign (Apr 27, 2017) | ||
17-42402899-G-C | Congenital generalized lipodystrophy type 4 | Likely benign (Apr 27, 2017) | ||
17-42402938-A-G | Congenital generalized lipodystrophy type 4 | Benign (Apr 27, 2017) | ||
17-42402983-G-C | Congenital generalized lipodystrophy type 4 | Benign (Apr 27, 2017) | ||
17-42403096-A-C | Congenital generalized lipodystrophy type 4 | Benign (Apr 27, 2017) | ||
17-42403138-G-A | Congenital generalized lipodystrophy type 4 | Uncertain significance (Jan 13, 2018) | ||
17-42403179-C-T | Congenital generalized lipodystrophy type 4 | Likely benign (Jan 12, 2018) | ||
17-42403208-C-T | Congenital generalized lipodystrophy type 4 | Uncertain significance (Jan 13, 2018) | ||
17-42403241-C-G | Congenital generalized lipodystrophy type 4 | Likely benign (Apr 27, 2017) | ||
17-42403374-C-A | Congenital generalized lipodystrophy type 4 | Uncertain significance (Jan 13, 2018) | ||
17-42403455-C-T | Congenital generalized lipodystrophy type 4 | Uncertain significance (Jan 12, 2018) | ||
17-42403473-C-T | Congenital generalized lipodystrophy type 4 | Uncertain significance (Jan 12, 2018) | ||
17-42403486-A-C | Congenital generalized lipodystrophy type 4 | Uncertain significance (Jan 12, 2018) | ||
17-42403502-A-G | Congenital generalized lipodystrophy type 4 | Uncertain significance (Jan 13, 2018) | ||
17-42403577-G-A | Congenital generalized lipodystrophy type 4 | Uncertain significance (Jan 13, 2018) | ||
17-42403688-G-A | Congenital generalized lipodystrophy type 4 | Uncertain significance (Jan 12, 2018) | ||
17-42403689-C-T | Congenital generalized lipodystrophy type 4 | Benign (Apr 27, 2017) | ||
17-42403781-C-T | Congenital generalized lipodystrophy type 4 | Benign (Apr 27, 2017) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CAVIN1 | protein_coding | protein_coding | ENST00000357037 | 2 | 21066 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00497 | 0.895 | 125730 | 0 | 17 | 125747 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.38 | 195 | 257 | 0.759 | 0.0000196 | 2482 |
Missense in Polyphen | 116 | 153.97 | 0.75337 | 1540 | ||
Synonymous | 1.08 | 108 | 123 | 0.876 | 0.00000997 | 806 |
Loss of Function | 1.40 | 5 | 9.71 | 0.515 | 4.26e-7 | 137 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000206 | 0.000206 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000545 | 0.0000527 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays an important role in caveolae formation and organization. Essential for the formation of caveolae in all tissues (PubMed:18056712, PubMed:18191225, PubMed:19726876). Core component of the CAVIN complex which is essential for recruitment of the complex to the caveolae in presence of calveolin-1 (CAV1). Essential for normal oligomerization of CAV1. Promotes ribosomal transcriptional activity in response to metabolic challenges in the adipocytes and plays an important role in the formation of the ribosomal transcriptional loop. Dissociates transcription complexes paused by DNA-bound TTF1, thereby releasing both RNA polymerase I and pre-RNA from the template (By similarity). {ECO:0000250|UniProtKB:O54724, ECO:0000269|PubMed:18056712, ECO:0000269|PubMed:18191225, ECO:0000269|PubMed:19726876}.;
- Disease
- DISEASE: Congenital generalized lipodystrophy 4 (CGL4) [MIM:613327]: A disorder characterized by the association of congenital generalized lipodystrophy with muscular dystrophy and cardiac anomalies. Congenital generalized lipodystrophy is characterized by a near complete absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes. {ECO:0000269|PubMed:19726876, ECO:0000269|PubMed:20684003}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Gene expression (Transcription);RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;EGFR1
(Consensus)
Recessive Scores
- pRec
- 0.265
Intolerance Scores
- loftool
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.66
Haploinsufficiency Scores
- pHI
- 0.593
- hipred
- Y
- hipred_score
- 0.672
- ghis
- 0.622
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Cavin1
- Phenotype
- muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; renal/urinary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- cavin1a
- Affected structure
- skeletal muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- convolute
Gene ontology
- Biological process
- transcription initiation from RNA polymerase I promoter;termination of RNA polymerase I transcription;rRNA transcription;positive regulation of cell motility
- Cellular component
- nucleus;nucleoplasm;cytoplasm;mitochondrion;endoplasmic reticulum;cytosol;plasma membrane;caveola;protein-containing complex;intracellular membrane-bounded organelle;membrane raft
- Molecular function
- RNA binding;protein binding;rRNA primary transcript binding;identical protein binding